OQROGet OQRO Pro
Insider trade

Lenz Therapeutics (LENZ)10% owner sold ~$1.76M

Versant Venture Capital VI, 10% owner at Lenz Therapeutics, sold ~$1.76M of Lenz Therapeutics shares.

~$1.76M
Approx. value · 41K sh @ $43.00
1.18M
Holds after · shares reported
Traded
Sep 18, 2025
Filed
Sep 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 15, 2025Insider · 1 personInsiders: 2 sales (~$8.5M)
  2. Aug 18, 2025Insider · 1 personInsiders: 2 sales (~$1.8M)
  3. Aug 22, 2025Insider · 1 personInsiders: 4 sales (~$1.6M)
  4. Aug 25, 2025Insider · 1 personInsiders: 4 sales (~$3.1M)
  5. Aug 26, 2025Insider · 1 personInsiders: 4 sales (~$2.8M)
  6. Sep 18, 2025 · this disclosureInsider10% owner sold ~$1.76M of LENZ shares in the open market

What came next

  1. Sep 18, 2025Insider · 1 personInsiders: 5 sales (~$4.0M)
  2. Nov 5, 2025Company filing · Form 8-K · ResultsReported its results
  3. Nov 7, 2025Insider · 2 peopleInsiders: 3 purchases (~$289K)
  4. Nov 17, 2025Insider · 1 personInsiders: 2 sales (~$261K)
  5. Jan 7, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Lenz Therapeutics

OQRO holds no insider, Congress, fund or contract record for Lenz Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LENZ page.

Other recent filings by Versant Venture Capital VI, L.P., 10% owner

The full history of Versant Venture Capital VI, L.P., 10% owner is on the profile page.

How this filing works

Other disclosures at Lenz Therapeutics

Everything OQRO holds on this company is on its LENZ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data